Heart valve checks in children with heart defects
Part of Genetic & congenital, Heart & circulation clinical trials.
This study uses ultrasound imaging of the heart to check how well the heart valves are working in children who were born with heart defects. It aims to understand valve problems better, which may help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child between 1 month and 18 years old
- You have a heart defect present from birth
- Your parent or guardian agrees to let you join
- You do not have rheumatic heart disease (a heart problem caused by untreated strep throat)
- You do not have cardiomyopathy (a disease of the heart muscle)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced CT scans to study people with moderate or severe heart valve disease. It aims to better understand valve problems and may help guide future treatments.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
This study uses MRI scans to look at heart problems in babies and children. It may help doctors understand the heart's structure better without using X-rays.
This study looks at how well a computer system can check children's health by listening to body sounds, like those from the heart, lungs, or belly. It is testing an AI system to see if it works well as an extra check alongside regular medical care.
This study uses routine heart scans (either echocardiogram or MRI) to better understand single-ventricle heart conditions. It may help improve how doctors evaluate and monitor your heart over time.
This study tests a new non-invasive device called UltraTrac that measures how well the heart pumps blood in people with congenital heart disease. It will be used during standard heart procedures or intensive care stays to see if it works as well as current methods.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.